The latest Investing Matters Podcast episode with Inclusive Asset Management's Alexandra McGuigan has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Feedback Interim Loss Widens But Excited For Change In Direction

Tue, 18th Feb 2020 10:54

(Alliance News) - Feedback PLC on Tuesday reported a widened loss in the first half as the company's expenses rose sharply on a shift in strategy.

For the six months to November 30, the medical imaging technology firm recorded a pretax loss of GBP691,000, widened from a GBP407,000 loss seen in the same period the year before.

Revenue was up 14% year-on-year to GBP269,000 from GBP236,000, but Feedback's operating expenses rose 49% to GBP956,000 from GBP642,000.

The rise in expenses was attributed to the company launching its new flagship product, Bleepa - a clinical messaging app. Feedback also noted it has completed a strategic review of its Cadran imaging device portfolio.

"We have deliberately changed the company's strategy to focus on the Cadran portfolio and transition into the emerging mobile medical market; this strategy is already bearing fruit," Chief Executive Tom Oakley said.

He continued: "During the past six months, we completed the development of our new flagship product, Bleepa. Following its launch in September at the NHS Expo, we have received significant interest and entered our first Pilot study within an NHS setting, from which early indications show great promise. We believe that Bleepa has the potential to revolutionise the way clinicians are able to communicate with each other and advance treatment of their patients, quickly."

Looking ahead, Feedback said its new strategy is expected to generate higher recurring revenue, as it moves away from a traditional software sales model towards a software as a service model.

"We believe the new strategy and subsequent development of Bleepa has transformed the company," Feedback said.

The company said the results from its Bleepa pilot study should be available in the coming months, which it hopes to convert into "meaningful contracts".

"Further evidence of the new strategy gaining traction is our first commercial contract of the Cadran platform outside of the NHS. With growing momentum and the strengthening of our board with the appointment of Adam Denning, 2020 is looking to be a promising year for Feedback," Oakley added.

Shares in Feedback were 5.3% lower in London on Tuesday at 0.81 pence each.

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

Related Shares

More News
25 Mar 2024 10:39

Feedback shares skyrocket on partnership for TB screening in India

(Alliance News) - Feedback PLC on Monday announced it will partner with the Heal Foundation in India to conduct tuberculosis screening projects.

21 Mar 2024 16:21

Feedback secures funding for Oldham pilot

(Sharecast News) - Feedback has secured £50,000 in funding to initiate a Community Diagnostic Centre (CDC) pathway pilot with the Oldham CDC, it ...

21 Mar 2024 11:26

Feedback secures GBP50,000 in funding for pathway pilot with Oldham

(Alliance News) - Feedback PLC on Thursday said that it has secured funding for another Community Diagnostic Centre pathway pilot with the Oldham CDC,...

21 Feb 2024 18:33

Feedback says interim revenue down, announces new pilot deal

(Alliance News) - Feedback PLC on Wednesday announced a new partnership with Medical Imaging Partnership, and a widened loss for its latest half year.

21 Feb 2024 13:15

Feedback inks fresh deal with Medical Imaging Partnership

(Sharecast News) - Feedback announced a significant development in its clinical infrastructure offerings on Wednesday, with radiology specialist Medic...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.